ExodusPoint Capital Management’s Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares) RAAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-9,848
Closed -$131K 2755
2021
Q3
$131K Sell
9,848
-7,825
-44% -$119K ﹤0.01% 1867
2021
Q2
$450K Buy
17,673
+2,600
+17% +$77.3K 0.01% 1511
2021
Q1
$621K Buy
+15,073
New +$992K 0.01% 1202

Other funds holding RAAS

ExodusPoint Capital Management's RAAS Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares) (RAAS) in Q4 2021, closing a stake of 9,848 shares — an estimated $131K sold.

ExodusPoint Capital Management first reported a position in RAAS in Q1 2021 and held it in 3 quarters. The position peaked at $621K in Q1 2021. 25 funds tracked by Wall St. Rank hold RAAS as of Q4 2021.

  • ExodusPoint Capital Management reported no remaining Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares) position as of Q4 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 9,848 Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares) shares in Q4 2021, an estimated $131K.
  • ExodusPoint Capital Management first reported a position in Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares) in Q1 2021 and held it in 3 quarters.
  • ExodusPoint Capital Management's Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares) position peaked at $621K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares) as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.